Therapeutic Hydrogels With Branched Polyamine Ionic Crosslinking

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing therapeutic hydrogels lack effective crosslinking agents and methods for sustained release of therapeutic agents, particularly in medical applications requiring precise control over pH and ionic interactions.

Innovation Solution

Therapeutic hydrogels comprising anionic polysaccharides crosslinked by branched polyamines, which are positively charged at pH 5.5 to 7.5, allowing for ionically crosslinked structures that can incorporate imaging agents and therapeutic agents for controlled release.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional crosslinking agents are used in therapeutic hydrogels, then hydrogel structure can be formed, but effective crosslinking and sustained release of therapeutic agents cannot be achieved

Engineering Contradiction:
Improvecrosslinking effectivenessVSAvoidsustained release capability
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent changes the chemical parameters of the crosslinking system by using branched polyamines with specific molecular weights (200-2000 Da) and specific numbers of primary amine groups (3-25 groups per molecule). This parameter optimization enables both effective crosslinking of anionic polysaccharides and sustained release of therapeutic agents, resolving the contradiction between crosslinking effectiveness and sustained release capability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite crosslinking system combining branched polyamines with anionic polysaccharides. The polyamine-polysaccharide complex forms a dual-function network that provides both structural integrity through crosslinking and controlled release of therapeutic agents, simultaneously achieving reliable crosslinking and sustained release.

Inventive Principle:
Principle #40Composite materials

2Reliability

If pH control is not optimized, then hydrogel formation is simpler, but stable therapeutic environment cannot be provided

Engineering Contradiction:
Improvetherapeutic environment stabilityVSAvoidpH control mechanism
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The branched polyamine crosslinking system self-regulates pH through its protonation/deprotonation equilibrium. The primary amine groups naturally buffer the environment at physiological pH (5.5-7.5) without requiring external pH control mechanisms, providing stable therapeutic conditions while maintaining system simplicity.

Inventive Principle:
Principle #25Self-service

3Ease of manufacture

If simple hydrogel structures are used, then ease of manufacture is improved, but effective therapeutic agent incorporation and release cannot be achieved

Engineering Contradiction:
Improvehydrogel fabrication simplicityVSAvoidtherapeutic agent delivery capability
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The branched polyamine crosslinking system performs multiple functions simultaneously: it crosslinks anionic polysaccharides to form hydrogel structure, provides pH buffering for therapeutic stability, and creates controlled release pathways for therapeutic agents. This multi-functionality is achieved through a single crosslinking mechanism, maintaining ease of manufacture while enabling versatile therapeutic delivery.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The hydrogels provide a stable, pH-controlled environment for sustained release of therapeutic agents, enhancing medical applications such as embolic agents, tissue sealants, and tissue augmentation, while allowing for imaging and therapeutic delivery.

Implementation Method 1

the branched polyamine is positively charged and comprises two or more positively charged primary amine groups at the pH of the therapeutic hydrogel, and wherein the branched polyamine ionically crosslinks the anionic polysaccharide

Methodology Applied
Scientific EffectIonic crosslinking: Ion Repulsion/Attraction

Data Source

PatentUS20250295585A1Therapeutic hydrogels
Publication Date: 2025.09.25 BOSTON SCIENTIFIC SCIMED INC
  • US20250295585A1 patent drawing

AI summary

The present disclosure pertains to therapeutic hydrogels that comprise an anionic polysaccharide crosslinked by a branched polyamine, wherein the branched polyamine comprises at least two primary amine groups, more typically at least three primary amine groups. The present disclosure also pertains to medical compositions that comprise such therapeutic hydrogels and to methods of medical treatment in which such therapeutic hydrogels are delivered to a patient in need of medical treatment.